Skip to main content
. 2015 Nov 4;2015:673512. doi: 10.1155/2015/673512

Figure 1.

Figure 1

Cell viability of mouse-derived 32D cells transfected with the BCR-ABL1 oncogene sensitive to imatinib (filled circles) or cells with primary resistance to imatinib caused by the Y253H mutation in BCR-ABL1 (filed squares) or acquired imatinib resistance (empty squares). Viability was evaluated by MTT assay. Each point is mean of six independent experiments; error bars represent SEM but in some points they were smaller than the symbol radius.